In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1-Deleted adenoviral vector

Human Gene Therapy

Volumn 8, Issue 6, 1997, Pages 755-764

  Cheng, David Y ^a   Kolls, Jay K ^b   Lei, Dinghua ^b   Noel, R Adam ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; COLON; CONTROLLED STUDY; DUODENUM; ENZYME HISTOCHEMISTRY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; ILEUM; INTESTINE EPITHELIUM CELL; JEJUNUM; MALE; NONHUMAN; RAT; REPORTER GENE; SMALL INTESTINE; VIRUS RECOMBINANT;

EID: 0030956977     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.6-755     Document Type: Article

References (31)

1. ALLEN, A. (1981). Structure and function of gastrointestinal mucus. In Physiology of the Gastrointestinal Tract. L.R. Johnson, ed. (Raven Press, New York) pp. 617-639.
2. ANDERSON, W.F. (1992). Human gene therapy. Science 256, 808-813.
3. BATRA, R.K., BERSCHNEIDER, H., and CURIEL, D.T. (1994). Molecular conjugate vectors mediate efficient gene transfer into gastrointestinal epithelial cells. Cancer Gene Ther. 3, 185-192.
4. BOWLES, N.E., EISENSMITH, R.C., MOHUIDDIN, R., PYRON, M., and WOO, S.L.C. (1996). A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vitro. Hum. Gene Ther. 7, 1735-1742.
5. COLLEDGE, W.H., RATCLIFF, R., FOSTER, D., WILLIAMSON, R., and EVANS, M.J. (1992). Cystic fibrosis mouse with intestinal obstruction. Lancet 340, 680.
6. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
7. FRIEDMANN, T. (1989). Progress toward human gene therapy. Sciences 244, 1275-1281.
8. GILBERT, M.A., CHARREAU, B., VICART, P., PAULIN, D., and NANDI, P.K. (1992). Mechanism of entry of a xenotropic MMuLV-derived recombinant retrovirus into porcine cells using the expression of the reporter nlslacZ gene. Arch. Virol. 124, 57-67.
9. GRAHAM, F.L., and PREVEC, L. (1991). Methods in Molecular Biology. E.J. Murray, ed. (Humana Press, Clifton, NJ) pp. 109-128.
10. HAMILTON, T.E., DEMATTEO, R.P., ROMBEAU, J.L., and RAPER, S.E. (1995). A comparison of adenoviral and retroviral gene transfer into the small intestine. Surg. Forum 66, 649-650.
11. HENNING, S.J. (1995). Gene transfer into the intestinal epithelium. Adv. Drug Deliv. Rev. 17, 341-347.
12. JACOMINO, M., LAU, C., JAMES, S.Z., SHUKLA, P., and HENNING, S.J. (1996). Gene transfer into fetal rat intestine. Hum. Gene Ther. 7, 1757-1762.
13. JONES, S.N., GROMPE, M., MUNIR, M.I., VERES, G., CRAIGEN, W.J., and CASKEY, C.T. (1990). Ectropic correction of ornithine transcarbamylase deficiency in sparse fur mice. J. Biol. Chem. 265, 14684-14690.
14. JOYNER, A., KELLER, G., PHILLIPS, R.A., and BERNSTEIN, A. (1983). Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells. Nature 305, 556-558.
15. KATZ, P., and FAUCI, A.S. (1988). Immunosuppressants and immunoadjuvants. In M. Samter, D.W. Talmadge, M.M. Frank, K.F. Austen, and H.N. Claman, eds. Immunological Diseases, 4th ed. (Little, Brown, Boston) p. 675.
16. KOLLS, J.K., PEPPEL, K., SILVA, M., and BEUTLER, B. (1994). Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91, 215-219.
17. KOLLS, J.K., LEI, D.G., ODOM, G., NELSON, S., SUMER, W.R., GERBER, M.A., and SHELLITO, J.D. (1996). Use of transient cP4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum. Gene Ther. 7, 489-497.
18. LAU, C., SORIANO, H.E., LEDLEY, F.D., FINEGOLD, M.J., WOLFE, J.H., BIRKENMEIER, E.H., and HENNING, S.J. (1995). Retroviral gene transfer into intestinal epithelium. Hum. Gene Ther. 6, 1145-1151.
19. LEI, D.G., LEHMANN, M., SCHELLITO, J.E., NELSON, S., SIEGLING, A., VOLK, H., and KOLLS, J.K. (1996). Non-depleting anti-CD4 antibody treatment prolong lung-directed E1-deleted adenovirus-mediated gene expression in rats. Hum. Gene Ther. 7, 2273-2279.
20. MACGREGOR, G.R., MOGG, A.E., BUTKR, J.F., and CASKEY, C.T. (1987). Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene. Somat. Cell Genet. 13, 253-265.
21. MILLER, A.D. (1992). Human gene therapy comes of age. Nature 357, 455-460.
22. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, G327-G331.
23. NOEL, R.A., SHUKLA, P., and HENNING, S.J. (1994). Optimization of gene transfer into intestinal epithelial cells using a retroviral vector. J. Pediatr. Gastroenterol. Nutr. 19, 43-49.
24. SANDBERG, J.W., LAU, C., JACOMINO, M., FINEGOLD, M., and HENNING, S.J. (1994). Improving access to intestinal cells as a step toward intestinal gene transfer. Hum. Gene Ther. 5, 323-329.
25. SEKON, H.S., and LARSON, J.E. (1995). In utero gene transfer into the pulmonary epithelium. Nature Med. 1, 1201-1203.
26. SNOUWAERT, J.N., BRIGMAN, K.K., LATOUR, A.M., MALOUF, N.N., BOUCHER, R.C., SMITHIES, O., and KOLLER, B.H. (1992). An animal model for cystic fibrosis made by gene targeting. Science 257, 1083-1088.
27. SWEETSER, D.A., HAUFT, S.M., HOOOE, P.C., BIRKENMEIER, E.H., and GORDON, J.I. (1988). Transgenic mice containing intestinal fatty acid-binding protein-human growth hormone fusion genes exhibit correct regional and cell-specific expression of the reporter gene in their small intestine. Proc. Natl. Acad. Sci. USA 85, 9611-9615.
28. TAKEHARA, T., HAYASHI, N., YAMAMOTO, M., MIYAMOTO, Y., FUSAMOTO, H., and KAMDA, T. (1996). In vivo gene transfer and expression in rat stomach by submucosal injection of plasmid DNA. Hum. Gene Ther. 7, 589-593.
29. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
30. YOUNG, D.C., KINGSLEY, S.D., RYAN, K.A., and DUTKO, F.J. (1993). Selective inactivation of eukaryotic β-Gal in assays for inhibitions of HIV TAT using bacterial β-Gal as reporter enzyme. Anal. Biochem. 215, 24-30.
31. ZSUZSANNA, K., ZSENGELLER, K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.